Latest Posts › Coronavirus/COVID-19

Share:

Coronavirus: The Hill and the Headlines, October 2020 # 15

In Washington: After several consecutive days of talks between House Speaker Nancy Pelosi (D-CA) and Treasury Secretary Steven Mnuchin it appears increasingly likely that Congress will have to wait to consider any COVID-19...more

Coronavirus: The Hill and the Headlines, October 2020 # 13

In Washington: House Speaker Nancy Pelosi (D-CA) and Treasury Secretary Steven Mnuchin continued negotiations on a fourth COVID-19 stimulus bill on Wednesday. Pelosi’s spokesman Drew Hammill sent a series of Tweets...more

Coronavirus: The Hill and the Headlines, October 2020 # 12

In Washington: Tuesday afternoon, House Speaker Nancy Pelosi (D-CA) said Democrats and the White House have moved closer to a deal on a fourth COVID-19 stimulus relief bill ahead of her latest call with Treasury Secretary...more

COVID-19 Report for Life Sciences and Health Care Companies (UPDATED)

Tuesday, 20 October 2020 - President Trump’s executive order on essential medicines aims to encourage pharmaceutical companies to bring their manufacturing back to the U.S. But it may also have unintended consequences for...more

Coronavirus: The Hill and the Headlines, October 2020 #11

In Washington: House Speaker Nancy Pelosi (D-CA) set a Tuesday deadline for her and Treasury Secretary Steven Mnuchin to reconcile significant policy disputes if they want to pass a coronavirus relief bill before Election...more

Coronavirus: The Hill and the Headlines, October 2020 # 10

In Washington: State public health officials are urging Congress to provide at least $8.4 billion in emergency funding for distributing a coronavirus vaccine, warning that they lack enough money to carry out the immense...more

Coronavirus: The Hill and the Headlines, October 2020 # 9

In Washington: President Trump said Thursday that he is willing to go higher than his current $1.8 trillion offer for the next coronavirus stimulus package as negotiations continue. “Go big or go home,” Trump told Fox...more

Coronavirus: The Hill and the Headlines, October 2020 # 8

In Washington - Secretary Steven Mnuchin and Speaker Nancy Pelosi spoke for an hour Wednesday morning and plan to speak again tomorrow. Mnuchin says they continue to “make progress” while Pelosi’s spokesperson says the...more

Coronavirus: The Hill and the Headlines, October 2020 # 7

In Washington: Hopes for a quick resolution to the stimulus talks continue to fade though House Speaker Nancy Pelosi (D-CA) and Treasury Secretary Steven Mnuchin continue talking this week to try and bridge the gap between...more

Coronavirus: The Hill and the Headlines, October 2020 # 6

In Washington: On a conference call Saturday, Senate Republicans relayed their objections to another enormous coronavirus relief package to party leaders and top Trump officials. Members cited that Republican voters have...more

COVID-19 Report for Life Sciences and Health Care Companies (UPDATED)

Tuesday, 13 October 2020 - The Hogan Lovells Government Relations and Public Affairs group is tracking all of the latest developments in the U.S. Congress and relevant news stories. President Trump and his aides on Friday...more

COVID-19 Report for Life Sciences and Health Care Companies (UPDATED)

The COVID-19 Report is a compilation of coronavirus news, analysis, and insights from around the world to help life sciences and health care companies stay current in this challenging time. ...more

Coronavirus: The Hill and the Headlines, October 2020 # 3

In Washington: As planned, the House of Representatives is on recess through the election but Democratic leadership may call members back for a potential vote on a coronavirus stimulus bill. Senate Majority Leader Mitch...more

Coronavirus: The Hill and the Headlines – COVID-19 D.C. Update – October # 2

In Washington: President Donald Trump and first lady Melania Trump have tested positive for the coronavirus, the White House physician announced late Thursday.  The President tweeted at 12:54 a.m. Friday: “Tonight, @FLOTUS...more

Coronavirus: The Hill and the Headlines – COVID-19 D.C. Update – September # 18

In Washington: House Speaker Nancy Pelosi (D-CA) and Treasury Secretary Steven Mnuchin were unable to come to an agreement on a coronavirus relief deal after meeting Wednesday afternoon. The Speaker says the House will...more

COVID-19 Report for Life Sciences and Health Care Companies (UPDATED)

In Tuesday's Report: Germany clarifies restrictions on dispensing in-vitro diagnostic kits, UK partners with Valneva on vaccine production, U.S. CDC reverts to older guidance, HHS bars health agencies from signing new rules,...more

COVID-19 Report for Life Sciences and Health Care Companies (UPDATED)

The COVID-19 Report is a compilation of coronavirus news, analysis, and insights from around the world to help life sciences and health care companies stay current in this challenging time. In Tuesday's Report: FDA...more

COVID-19 Report for Life Sciences and Health Care Companies (UPDATED)

The COVID-19 Report is a compilation of coronavirus news, analysis, and insights from around the world to help life sciences and health care companies stay current in this challenging time. ...more

COVID-19 Report for Life Sciences and Health Care Companies (UPDATED)

The COVID-19 Report is a compilation of coronavirus news, analysis, and insights from around the world to help life sciences and health care companies stay current in this challenging time....more

COVID-19 Report for Life Sciences and Health Care Companies (UPDATED)

The COVID-19 Report is a compilation of coronavirus news, analysis, and insights from around the world to help life sciences and health care companies stay current in this challenging time....more

COVID-19 Report for Life Sciences and Health Care Companies

In Tuesday's report: FDA issues first EUA for sample pooling, closes its COVID-19 hotline, and extends HCT/P enforcement discretion; a litigation team podcast on work return risks; Virginia establishes COVID-19 workplace...more

Braving a perfect storm: Avoiding legal and reputational risk associated with CARES Act oversight and investigations

Businesses across the United States have been battered by the COVID-19 crisis and many companies have been the recipients of unprecedented levels of economic assistance and tax relief under the Coronavirus Aid, Relief, and...more

152 Results
 / 
View per page
Page: of 7

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide